Global Indirect Procurement at Fresenius Kabi plays a critical role in enabling innovation, ensuring governance, and creating sustainable value across the organization. We are looking for an experienced professional to manage a strategic global R&D services portfolio and partner closely with senior stakeholders across Research, Clinical Operations and Medical Affairs.
Execute global category strategies for R&D and professional services in alignment with the Category Lead
Translate global strategy into annual sourcing plans and manage a sustainable sourcing pipeline
Lead and co‑lead complex end‑to‑end sourcing initiatives, including tenders, RFPs and negotiations
Drive cost savings and value creation across a complex, knowledge‑based services portfolio
Negotiate commercial, contractual and service‑level agreements (MSA, SOW, SLA, WO)
Manage contract lifecycle activities including amendments, renewals and work orders
Ensure compliance with global procurement policies, financial controls and risk standards
Manage supplier performance and deploy a global strategic supplier ecosystem across business units
Act as a trusted business partner to R&D, Clinical Operations, Medical Affairs and cross‑functional teams
Bachelor’s degree in Business, Supply Chain, Sciences or a related field
Master’s degree or advanced procurement certifications are a plus
Strong experience in strategic sourcing and category management with hands‑on execution
Solid exposure to procurement of R&D and clinical services
Advanced negotiation and contract management skills
Strong stakeholder management and communication skills in a global, matrix environment
Analytical, data‑driven mindset with the ability to balance strategy and execution
Advanced MS Office skills; experience with SAP Ariba or SAP ERP is an advantage
Drive the future of Global Indirect Procurement — join #futurefresenius and apply now through our online portal to make an impact!
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint
